IL-21 Selectively Protects CD62L<sup>+</sup> NKT Cells and Enhances Their Effector Functions for Adoptive Immunotherapy.

Ngai, Ho; Tian, Gengwen; Courtney, Amy N; Ravari, Soodeh B; Guo, Linjie; Liu, Bin; Jin, Jingling; Shen, Elise T; Di Pierro, Erica J; Metelitsa, Leonid S

IL-21 Selectively Protects CD62L⁺ NKT Cells and Enhances Their Effector Functions for Adoptive Immunotherapy.

Ngai, Ho; Tian, Gengwen; Courtney, Amy N; Ravari, Soodeh B; Guo, Linjie; Liu, Bin; Jin, Jingling; Shen, Elise T; Di Pierro, Erica J; Metelitsa, Leonid S.

Afiliación

Ngai H; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030.
Tian G; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030; and.
Courtney AN; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030.
Ravari SB; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030; and.
Guo L; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030.
Liu B; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030.
Jin J; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030.
Shen ET; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030.
Di Pierro EJ; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030.
Metelitsa LS; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030.

J Immunol ; 201(7): 2141-2153, 2018 10 01.

Article en En | MEDLINE | ID: mdl-30111631

Asunto(s)

Inmunoterapia Adoptiva/métodos; Interleucinas/metabolismo; Linfoma de Células B/terapia; Células T Asesinas Naturales/inmunología; Células TH1/inmunología; Animales; Línea Celular Tumoral; Células Cultivadas; Citotoxicidad Inmunológica; Galactosilceramidas/inmunología; Granzimas/metabolismo; Humanos; Interleucina-2/metabolismo; Selectina L/metabolismo; Activación de Linfocitos; Linfoma de Células B/inmunología; Ratones; Células T Asesinas Naturales/trasplante; Trasplante de Neoplasias; Receptores de Antígenos de Linfocitos T alfa-beta/metabolismo

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfoma de Células B / Interleucinas / Células TH1 / Células T Asesinas Naturales Límite: Animals / Humans Idioma: En Revista: J Immunol Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google